Amazingly, together with the team of Prof. Dr. Thomas Pabst at the Inselspital Bern, we have successfully completed our second prospective interventional trial!
In the DARTT-1 study (NCT05732688), patients suffering from Acute Myeloid Leukemia (AML) that had exhausted all registered treatment options received pharmacoscopy guided treatment. Strikingly, patients receiving high-scoring treatments lived three times longer (>3x OS) than patients receiving low-scoring treatments.
The study results are published open access in Haematologica. Efforts in the lab were led by teamwork between Yannik Severin, Yasmin Festl, and at the Inselspital by Jonas Schmid.